Cardiovascular

A study from Duke University indicated that NMN supplementation improves function in mice with heart disease via boosting NAD+ levels and SIRT3 activity.

Scientists found NMN administration preserved mitochondrial health and prevented heart failure in mice deficient in a molecule that makes them susceptible to heart disease.

Supplementing mice with nicotinamide mononucleotide (NMN) reverses age-related artery dysfunction, a key contributor to cardiovascular disease.

Ischemia, the inadequate blood supply to body parts, can lead to life-threatening conditions. Scientists found that NMN may be a new intervention for it.

Researchers from China find nicotinamide mononucleotide (NMN) protects tissue and improves damage in mice following intracerebral hemorrhage.